CSL Aktie

85,00 EUR +2,00 EUR +2,41 %

03.01.2025

FSE

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

KGV36,04Div. Rendite1,24%

WKNA115DF

ISINUS12637N2045

SymbolCSLLY

CSL Aktien News

Sortieren:Datum Meistgelesen

17.08.22PR NewswireCSL announces carbon emissions reduction targets

10.08.22PR NewswireCSL LAUNCHES NEW UNIFIED GLOBAL BRAND IDENTITY

04.08.22PR NewswireCSL Plasma Reimagines Donor Experience With First Donations Completed on Innovative Plasma Collection Technology

11.07.22PR NewswireSeqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2022/23 U.S. Season

22.06.22PR NewswireCDC Advisory Committee Includes FLUAD® QUADRIVALENT as a Preferentially Recommended Influenza Vaccine for Adults 65 and Older

09.06.22PR NewswireAcclaimed Photographer Rankin and CSL Behring Team Up to Launch 'Portraits of Progress', an Exhibition Chronicling the Past, Present and Future of Life with Hemophilia

06.06.22PR NewswireSeqirus Completes $156 Million Expansion to Holly Springs Manufacturing Facility, Optimizing Global Manufacturing Capabilities for Seasonal and Pandemic Influenza Vaccines

02.06.22PR NewswireSeqirus' Holly Springs Manufacturing Facility Designated by U.S. Government as Pandemic Ready

24.05.22PR NewswireFDA Accepts CSL Behring's Biologics License Application for Etranacogene Dezaparvovec for Priority Review

11.05.22PR NewswireWalter Charles Named Senior Vice President and General Manager of CSL Plasma

28.04.22PR NewswireCSL Behring Donates 500 Million International Units of Coagulation Factor Replacement Therapy to the World Federation of Hemophilia Humanitarian Aid Program to Help Those Living with Bleeding Diso...

28.03.22PR NewswireEuropean Medicines Agency Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec for People with Hemophilia B

02.03.22PR NewswireForbes Magazine Ranks Global Biotech Leader CSL Among America's Best Employers for 2022

25.02.22PR NewswireSeqirus and U.S. Government Renew Multi-Year Agreement for Influenza Pandemic Preparedness and Response

22.02.22PR NewswireCSL Plasma Makes $125,000 Donation to American Red Cross for Disaster Relief in U.S. Communities

07.02.22PR NewswireSeqirus, a Business of CSL Limited, Announces New Facility Supporting Research & Development of Leading-Edge Influenza Vaccine Technology

04.02.22PR NewswireFinal Analysis of Pivotal HOPE-B Study Demonstrates Durable and Sustained Therapeutic Effect of Etranacogene Dezaparvovec Gene Therapy in Hemophilia B - Data Presented at EAHAD 2022

18.01.22PR NewswireCSL BEHRING AG PUBLISHES OFFER PROSPECTUS ON PUBLIC TENDER OFFER FOR ALL PUBLICLY HELD SHARES OF VIFOR PHARMA LTD.

06.05.20ReutersUPDATE 1-Top Australian biotech firm CSL joins virus treatment race

06.05.20ReutersAustralia's CSL to start work on immunoglobulin product to treat COVID-19

09.04.20ReutersAustralia's CSL stands by profit guidance due to strong demand for blood products

11.02.20ReutersUPDATE 1-Australia's CSL posts 8% rise in H1 profit; raises FY outlook

11.02.20ReutersAustralia's CSL posts 8% rise in H1 profit; raises FY outlook

CSL News

CSL News: auf dieser Seite finden Sie alle CSL News und Nachrichten zur CSL Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch CSL News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um CSL News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.